Following news last week that it has begun appointing distributors for Remplir in the United States, Orthocell has announced clearance to begin selling the nerve repair product in Canada, a market it estimates to be worth $US 75 million. In an ASX statement on Wednesday, Orthocell said it has received a Medical Device Licence (MDL)…
Whyalla steel works produces first structural steel The Managing Director of Liberty Steel Group Tony Swiericzuk at Whyalla in South Australia has celebrated the completion of repairs and start up activities at the primary steel producer. Swiericzuk took to social media and said: “After a 48 hour reheat furnace start up programme, the Whyalla Steelworks…
Orthocell’s strong sales growth Tissue regeneration technology developer Orthocell has announced sales growth across its product portfolio, with total revenue for FY24 of $6.72 million – up 30.40 percent from FY23. Record revenue of $1.84m was achieved for the June 24 Quarter, up 14.41 percent. With Striate+ currently sold in the US, Europe/UK, Australia and…
Austal’s 18th LCS warship for the US Navy completes acceptance trials The future USS Kingsville constructed by Austal USA, part of the Perth-based shipbuilder Austal, has successfully completed acceptance trials in the Gulf of Mexico for the U.S. Navy. During acceptance trials, comprehensive testing is conducted on the ship’s major systems and equipment in order…